Health
Breakthrough in Melanoma Treatment: Personalized mRNA Therapy Achieves Phase 3 Success
By Editor • August 19, 2026 • 1 min read
Merck and Moderna's personalized mRNA therapy intismeran autogene achieves a milestone in melanoma treatment with positive phase 3 trial results.
Read more